T1	Intervention 716 846	randomized and dosed with either lopinavir/ritonavir monotherapy (n = 83) or lopinavir/ritonavir + zidovudine/lamivudine (n = 53).
T2	Intervention 847 935	We focus here on patients in the lopinavir/ritonavir monotherapy arm followed to week 96
